These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3379793)

  • 1. [Studies on platelet function, especially platelet fibrinogen, in patients with thrombasthenia and essential athrombia].
    Endo Y; Iwamoto K; Mamiya S; Niitsu H; Miura A
    Rinsho Byori; 1988 Feb; 36(2):207-12. PubMed ID: 3379793
    [No Abstract]   [Full Text] [Related]  

  • 2. [Platelet membrane abnormalities in thrombasthenia and essential athrombia (author's transl)].
    Ando Y; Watanabe K; Yamamoto M; Ikeda Y; Muraki H; Kikuchi M; Matsuda S; Yamada K; Takahashi R
    Nihon Ketsueki Gakkai Zasshi; 1978 Oct; 41(5):966-71. PubMed ID: 735708
    [No Abstract]   [Full Text] [Related]  

  • 3. Congenital platelet function disorders: survey findings and pathophysiology.
    Yasunaga K
    Nihon Ketsueki Gakkai Zasshi; 1986 Dec; 49(8):1499-508. PubMed ID: 3564845
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnosis of heterozygotes in Glanzmann's thrombasthenia.
    Stormorken H; Gogstad GO; Solum NO; Pande H
    Thromb Haemost; 1982 Oct; 48(2):217-21. PubMed ID: 6217584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on released-ADP and membrane glycoprotein in platelets of patients with Glanzmann's thrombasthenia and essential athrombia (author's transl)].
    Hayashi H; Niiya K; Koya H; Nozaki H; Kitazima K; Kimura I
    Rinsho Ketsueki; 1978 Oct; 19(10):1306-13. PubMed ID: 153981
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular mechanisms of platelet aggregation.
    Leung L; Nachman R
    Annu Rev Med; 1986; 37():179-86. PubMed ID: 3010804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A variant of Glanzmann's thrombasthenia with abnormal glycoprotein IIb-IIIa complexes in the platelet membrane.
    Nurden AT; Rosa JP; Fournier D; Legrand C; Didry D; Parquet A; Pidard D
    J Clin Invest; 1987 Mar; 79(3):962-9. PubMed ID: 3818957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Variant of Paris-I Lariboisière thrombasthenia, a molecular anomaly of the IIb-IIIa platelet glycoprotein complex].
    Caen JP; Rosa JP; Soria C; Boizard B
    C R Seances Acad Sci III; 1983; 296(10):479-81. PubMed ID: 6223690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Unusual features in Glanzmann thrombasthenia; proliferation of B-lymphocytes, lead poisoning].
    Bucher U
    Schweiz Med Wochenschr; 1988 Oct; 118(42):1510-27. PubMed ID: 3059486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of platelet function and proteins in 3 patients with Glanzmann's thrombasthenia.
    Weiss HJ; Kochwa S
    J Lab Clin Med; 1968 Jan; 71(1):153-65. PubMed ID: 4864595
    [No Abstract]   [Full Text] [Related]  

  • 11. Haemostatic function in coronary artery disease (CAD).
    Gupta A; Sikka M; Madan N; Dwidedi S; Rusia U; Sharma S
    Indian J Pathol Microbiol; 1997 Apr; 40(2):133-7. PubMed ID: 9257498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Platelet function tests (aggregation, release reaction, adhesion)].
    Ozaki Y
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():720-5. PubMed ID: 15658434
    [No Abstract]   [Full Text] [Related]  

  • 13. [Two cases of type II thrombasthenia].
    Shinmyozu K; Maruyama Y; Maruyama I; Osame M; Igata A
    Rinsho Ketsueki; 1986 Apr; 27(4):576-82. PubMed ID: 2942713
    [No Abstract]   [Full Text] [Related]  

  • 14. [Paris-I-Lariboisière variant thrombasthenia. Functional disorder of human platelet aggregation, glycoprotein-independent].
    Caen JP
    C R Acad Sci III; 1985; 300(10):417-9. PubMed ID: 3922568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the origin of platelet-associated fibrinogen.
    Karpatkin M; Howard L; Karpatkin S
    J Lab Clin Med; 1984 Aug; 104(2):223-37. PubMed ID: 6205112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombocyte function in acute leukemia].
    Shitikova AS
    Arkh Patol; 1978; 40(9):85-91. PubMed ID: 708283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responses of platelets to strains of streptococcus sanguis: findings in healthy subjects, Bernard-Soulier, Glanzmann's, and collagen-unresponsive patients.
    Soberay AH; Herzberg MC; Rudney JD; Nieuwenhuis HK; Sixma JJ; Seligsohn U
    Thromb Haemost; 1987 Apr; 57(2):222-5. PubMed ID: 3603413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of specific adhesion substrates for diagnosis of platelet disorders: platelet-collagen and platelet-fibrinogen interaction in von Willebrand's disease and Glanzmann's thrombasthenia.
    Misselwitz F; Gorbunova NA; Likhacheva EA; Leytin VL; Repin VS
    Thromb Res; 1987 Dec; 48(5):597-602. PubMed ID: 3502043
    [No Abstract]   [Full Text] [Related]  

  • 19. Triton X-114 phase separation of platelet membrane glycoproteins from normal subjects and a patient with type I thrombasthenia.
    Khanduri U; Clark S; Walker ID; Chamberlain KG; Penington DG
    Thromb Haemost; 1986 Feb; 55(1):98-103. PubMed ID: 3518135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative determination of platelet fibrinogen.
    Karaca M; Nilsson IM; Hedner U
    J Lab Clin Med; 1971 Mar; 77(3):485-9. PubMed ID: 4995007
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.